Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2287]
News [5245]
Articles [128]
Editorials [4]
Conferences [157]
elearning [13]
Different treatment strategies for BRCA positive breast cancer
Prof Banu Arun - MD Anderson Center, Houston, USA
Different treatment strategies for BRCA positive breast cancer ( Prof Banu Arun - MD Anderson Center, Houston, USA )
25 Jan 2018
Neoadjuvant and adjuvant therapy in triple negative breast cancer
Prof Banu Arun - MD Anderson Center, Houston, USA
Neoadjuvant and adjuvant therapy in triple negative breast cancer ( Prof Banu Arun - MD Anderson Center, Houston, USA )
25 Jan 2018
The DESKTOPIII trial in platinum-sensitive ovarian cancer
Prof Sean Kehoe - University of Birmingham, Birmingham, UK
The DESKTOPIII trial in platinum-sensitive ovarian cancer ( Prof Sean Kehoe - University of Birmingham, Birmingham, UK )
24 Jan 2018
Expert insight: Managing neutropenia in breast cancer patients
Dr Matti Aapro and Prof Hope Rugo
Expert insight: Managing neutropenia in breast cancer patients ( Dr Matti Aapro and Prof Hope Rugo )
23 Jan 2018
Focus on screening, not biomarkers
Dr Hain Van Poppel - European Association of Urology, Arnhem, The Netherlands
Focus on screening, not biomarkers ( Dr Hain Van Poppel - European Association of Urology, Arnhem, The Netherlands )
14 Dec 2017
Venetoclax plus rituximab for patients with relapsed / refractory CLL
Prof John Seymour - Peter MacCallum Cancer Centre, Melbourne, Australia
Venetoclax plus rituximab for patients with relapsed / refractory CLL ( Prof John Seymour - Peter MacCallum Cancer Centre, Melbourne, Australia )
12 Dec 2017
Daratumumab plus bortezomib, melphalan, and prednisone versus bortezomib...
Prof Meletios Dimopoulos - National and Kapodistrian University of Athens...
Daratumumab plus bortezomib, melphalan, and prednisone versus bortezomib, melphalan, and prednisone for multiple myeloma ( Prof Meletios Dimopoulos - National and Kapodistrian University of Athens, Athens, Greece )
12 Dec 2017
ASH 2017: Immunotherapy for multiple myeloma
Prof Paul Richardson & Dr Wenming Chen
ASH 2017: Immunotherapy for multiple myeloma ( Prof Paul Richardson & Dr Wenming Chen )
12 Dec 2017
Multiple myeloma highlights from ASH 2017
Prof Meral Beksac - Ankara University Medical School, Ankara, Turkey
Multiple myeloma highlights from ASH 2017 ( Prof Meral Beksac - Ankara University Medical School, Ankara, Turkey )
12 Dec 2017
Multiple myeloma analysis from ASH 2017
Dr Maxim Solovev and Dr Sung-Soo Yoon
Multiple myeloma analysis from ASH 2017 ( Dr Maxim Solovev and Dr Sung-Soo Yoon )
12 Dec 2017
Daratumumab, lenalidomide, and dexamethasone versus lenalidomide and...
Prof Meletios Dimopoulos - National and Kapodistrian University of Athens...
Daratumumab, lenalidomide, and dexamethasone versus lenalidomide and dexamethasone in multiple myeloma ( Prof Meletios Dimopoulos - National and Kapodistrian University of Athens, Athens, Greece )
11 Dec 2017
REGN2810 alone or in combination with REGN1979 for B-lymphoid malignancies
Dr Max Topp - University of Wurzburg, Wurzburg, Germany
REGN2810 alone or in combination with REGN1979 for B-lymphoid malignancies ( Dr Max Topp - University of Wurzburg, Wurzburg, Germany )
11 Dec 2017

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation